This psychedelic could help ease treatment-resistant depression

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestyleA new study has revealed that a single dose of magic mushrooms could significantly ease depression and help with treatment-resistant symptoms.The publicly-funded trial, led by King's College London and published in Nature Medicine, involved 60 participants with depression that had not responded to two previous treatments. Results showed that 40 per cent of patients receiving psilocybin entered remission from their depressive symptoms within three weeks, compared to just 3 per cent in the placebo group. More than four in ten (43 per cent) of those given psilocybin met the threshold for treatment response after three weeks, rising to 56 per cent after six weeks.Professor James Rucker, of King’s College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN), said: “This trial makes a strong case for larger publicly funded trials of psilocybin therapy in community settings, which are often more convenient and less anxiety-provoking for patients than hospital settings.”In fullMagic mushrooms can ease depression resistant to other treatments, major study findsMore bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Raccontata daindependent.co.ukmirror.co.uk